# Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid

> **NCT02617745** · PHASE2 · COMPLETED · sponsor: **Centre Henri Becquerel** · enrollment: 244 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **OTHER:** Platelet level determination

## Key facts

- **NCT ID:** NCT02617745
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-30
- **Primary completion:** 2022-11-28
- **Final completion:** 2024-06-05
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617745, "Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02617745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*